Bullock R, Zauner A, Woodward J J, Myseros J, Choi S C, Ward J D, Marmarou A, Young H F
Department of Pharmacology, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298, USA.
J Neurosurg. 1998 Oct;89(4):507-18. doi: 10.3171/jns.1998.89.4.0507.
Recent animal studies demonstrate that excitatory amino acids (EAAs) play a major role in neuronal damage after brain trauma and ischemia. However, the role of EAAs in patients who have suffered severe head injury is not understood. Excess quantities of glutamate in the extracellular space may lead to uncontrolled shifts of sodium, potassium, and calcium, disrupting ionic homeostasis, which may lead to severe cell swelling and cell death. The authors evaluated the role of EEAs in human traumatic brain injury.
In 80 consecutive severely head injured patients, a microdialysis probe was placed into the gray matter along with a ventriculostomy catheter or an intracranial pressure (ICP) monitor for 4 days. Levels of EAAs and structural amino acids were analyzed using high-performance liquid chromatography. Multifactorial analysis of the amino acid pattern was performed and its correlations with clinical parameters and outcome were tested. The levels of EAAs were increased up to 50 times normal in 30% of the patients and were significantly correlated to levels of structural amino acids both in each patient and across the whole group (p < 0.01). Secondary ischemic brain injury and focal contusions were most strongly associated with high EAA levels (27+/-22 micromol/L). Sustained high ICP and poor outcome were significantly correlated to high levels of EAAs (glutamate > 20 micromol/L; p < 0.01).
The release of EAAs is closely linked to the release of structural amino acids and may thus reflect nonspecific development of membrane micropores, rather than presynaptic neuronal vesicular exocytosis. The magnitude of EAA release in patients with focal contusions and ischemic events may be sufficient to exacerbate neuronal damage, and these patients may be the best candidates for treatment with glutamate antagonists in the future.
近期的动物研究表明,兴奋性氨基酸(EAA)在脑外伤和缺血后的神经元损伤中起主要作用。然而,EAA在重度颅脑损伤患者中的作用尚不清楚。细胞外空间中过量的谷氨酸可能导致钠、钾和钙的失控转移,破坏离子稳态,这可能导致严重的细胞肿胀和细胞死亡。作者评估了EAA在人类创伤性脑损伤中的作用。
在80例连续的重度颅脑损伤患者中,将微透析探头与脑室造瘘导管或颅内压(ICP)监测器一起置于灰质中4天。使用高效液相色谱法分析EAA和结构氨基酸的水平。对氨基酸模式进行多因素分析,并测试其与临床参数和预后的相关性。30%的患者中EAA水平升高至正常水平的50倍,并且在每个患者以及整个组中EAA水平均与结构氨基酸水平显著相关(p<0.01)。继发性缺血性脑损伤和局灶性挫伤与高EAA水平(27±22微摩尔/升)相关性最强。持续的高ICP和不良预后与高EAA水平(谷氨酸>20微摩尔/升;p<0.01)显著相关。
EAA的释放与结构氨基酸的释放密切相关,因此可能反映了膜微孔的非特异性形成,而不是突触前神经元囊泡的胞吐作用。局灶性挫伤和缺血事件患者中EAA释放的程度可能足以加重神经元损伤,这些患者可能是未来使用谷氨酸拮抗剂治疗的最佳候选者。